Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navin Khattry

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian CohortSelma Zenia D'Silva, Anand Bodade, Shalaka Kadam, et al.
Journal of Ophthalmic & Vision Research|October 3, 2024
Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell TransplantationVijay Shetty, Priyanka Kashelkar, Sachin Punatar, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 19, 2025
Clinical Perspectives on Amyloidosis in India: A Systematic Literature ReviewSumeet Mirgh, Uday Yanamandra, Ganesh K Vishvanathan, et al.
Plos One|February 4, 2022
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)Anshul Agarwal, Aakanksha Khandelwal, Kavita Pal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 12, 2026
Second Primary Malignancies Post Autologous Stem-cell Transplant in Multiple Myeloma from India - Knowing the UnknownSumeet Mirgh, Athira Surendran, Sachin Punatar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Comparison of Outcomes of Donor Lymphocyte Infusions With or Without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic HSCTSachin Punatar, Vinodhini Murugaiyan, Komal Kumbhalwar, et al.
Cellular Signalling|December 4, 2023
Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemiaTarang Gaur, Ahlam Ali, Deepak Sharma, et al.
Indian Journal of Pathology & Microbiology|October 11, 2018
<i>BRAFV600E</i> mutation in hairy cell leukemia: A single-center experienceAsma Bibi, Shrutika Java, Shruti Chaudhary, et al.
American Journal of Hematology|June 20, 2014
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemiaCarlo Gambacorti-Passerini, Jorge E Cortes, Jeff H Lipton, et al.
Blood Cell Therapy|December 10, 2025
Incidence, Risk Factors, and Outcomes of Viral Reactivations in Alternative Donor Hematopoietic Stem Cell TransplantsAnant Gokarn, Vinodhini Murugaiyan, Sachin Punatar, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian CohortSelma Zenia D'Silva, Anand Bodade, Shalaka Kadam, et al.
Journal of Ophthalmic & Vision Research|October 3, 2024
Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell TransplantationVijay Shetty, Priyanka Kashelkar, Sachin Punatar, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 19, 2025
Clinical Perspectives on Amyloidosis in India: A Systematic Literature ReviewSumeet Mirgh, Uday Yanamandra, Ganesh K Vishvanathan, et al.
Plos One|February 4, 2022
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)Anshul Agarwal, Aakanksha Khandelwal, Kavita Pal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 12, 2026
Second Primary Malignancies Post Autologous Stem-cell Transplant in Multiple Myeloma from India - Knowing the UnknownSumeet Mirgh, Athira Surendran, Sachin Punatar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Comparison of Outcomes of Donor Lymphocyte Infusions With or Without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic HSCTSachin Punatar, Vinodhini Murugaiyan, Komal Kumbhalwar, et al.
Cellular Signalling|December 4, 2023
Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemiaTarang Gaur, Ahlam Ali, Deepak Sharma, et al.
Indian Journal of Pathology & Microbiology|October 11, 2018
<i>BRAFV600E</i> mutation in hairy cell leukemia: A single-center experienceAsma Bibi, Shrutika Java, Shruti Chaudhary, et al.
American Journal of Hematology|June 20, 2014
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemiaCarlo Gambacorti-Passerini, Jorge E Cortes, Jeff H Lipton, et al.
Blood Cell Therapy|December 10, 2025
Incidence, Risk Factors, and Outcomes of Viral Reactivations in Alternative Donor Hematopoietic Stem Cell TransplantsAnant Gokarn, Vinodhini Murugaiyan, Sachin Punatar, et al.
Pageof 12